Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-8bljj Total loading time: 0 Render date: 2024-06-13T18:26:56.612Z Has data issue: false hasContentIssue false

Chapter 21 - Mature T-Cell and NK-Cell Non-Hodgkin Lymphomas

from Section V - Mature Lymphoid Neoplasms

Published online by Cambridge University Press:  25 January 2024

Xiayuan Liang
Affiliation:
Children’s Hospital of Colorado
Bradford Siegele
Affiliation:
Children’s Hospital of Colorado
Jennifer Picarsic
Affiliation:
Cincinnati Childrens Hospital Medicine Center
Get access

Summary

Peripheral (mature) T-cell lymphomas (PTCLs) are much less common than B-cell lymphomas. Derived from post-thymic T-cells, PTCLs generally arise in lymphoid tissues “peripheral” to the thymus, such as the lymph nodes, spleen, gastrointestinal tract, and skin. Because natural killer (NK) cells and T-cells arise from a common progenitor cell and have some overlapping properties, NK-cell lymphomas are considered together with PTCLs in the World Health Organization (WHO) classification system [1].

PTCLs occur most frequently in adults and less frequently in children and adolescents. They comprise about 10–15% of all non-Hodgkin lymphomas (NHLs) in pediatric age groups [2]. NK-cell neoplasms are even rarer. Unlike adults, where there is a broad spectrum of T-cell neoplasms, the most common type of PTCL in pediatric patients is anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma, with other subtypes of PTCL (0.9%) being observed much less frequently [3].

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Macon, WR. Peripheral T-cell lymphomas. Hematopathology. 2018;1:306–39.Google Scholar
Perkins, SL. Pediatric mature T-cell and NK-cell non-Hodgkin lymphomas. In: Proytcheva, MA, eds. Diagnostic pediatric hematopathology. Cambridge, UK: Cambridge University Press; 2011:429–64.Google Scholar
Attarbaschi, A, Abla, O, Arias Padilla, L, et al. Rare non‐Hodgkin lymphoma of childhood and adolescence: a consensus diagnostic and therapeutic approach to pediatric‐type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T‐cell lymphoma. Pediatric Blood Cancer. 2020;67:e28416.Google Scholar
Falini, B, Lamant-Rochaix, L, Campo, E, et al. Anaplastic large cell lymphoma, ALK-positive. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:413–8.Google Scholar
Lamant-Rochaix, L, Feldman, AL, Delsol, G, et al. Anaplastic large cell lymphoma, ALK positive and ALK negative. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:673–91.Google Scholar
Montes-Mojarro, IA, Steinhilber, J, Bonzheim, I, et al. The pathological spectrum of systemic anaplastic large cell lymphoma (ALCL). Cancers. 2018;10:107.Google Scholar
Dunphy, CH, DeMello, DE, Gale, GB. Pediatric CD56+ anaplastic large cell lymphoma: a review of the literature. Arch Pathol Lab Med. 2006;130:1859–64.Google Scholar
Duyster, J, Bai, RY, Morris, SW. Translocations involving anaplastic lymphoma kinase (ALK). Oncogene. 2001;20:5623–37.Google Scholar
Liang, X, Branchford, B, Greffe, B, et al. Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma. J Pediatr Hematol Oncol. 2013;35:e209–13.Google Scholar
Feldman, AL, Harris, NL, Stein, H, et al. Anaplastic large cell lymphoma, ALK-negative. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:418–21.Google Scholar
Lamant-Rochaix, L, Feldman, AL, Delsol, G, et al. Anaplastic large cell lymphoma, ALK positive and ALK negative. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:673–91.Google Scholar
Ferreri, AJ, Govi, S, Pileri, SA, et al. Anaplastic large cell lymphoma, ALK-negative. Crit Rev Oncol Hematol. 2013;85:206–15.Google Scholar
Pileri, SA, Weisenburger, DD, Sng, I, et al. Peripheral T-cell lymphoma, NOS. In: Swerdlow, SH, Campo, E, Harris, NL, et al. eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:403–7.Google Scholar
de Level, L. Peripheral T-cell lymphoma, not otherwise specified. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:641–57.Google Scholar
Mellgren, K, Attarbaschi, A, Abla, O, et al. Non-anaplastic peripheral T cell lymphoma in children and adolescents – an international review of 143 cases. Ann Hematol. 2016;95:1295–305.Google Scholar
Iqbal, J, Weisenburger, DD, Greiner, TC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood. 2010;115:1026–36.Google Scholar
Chan, JKC, Quintanilla-Martinez, L, Ferry, JA, et al. Extranodal NK/T-cell lymphoma, nasal type. In: Swerdlow, SH, Campo, E, Harris, NL, et al. eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:368–71.Google Scholar
Ko, YH, Chan, JKC, Quintanilla-Martinez, L. Virally associated T-cell and NK-cell lymphoma. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:565–98.Google Scholar
Gaulard, P, Jeffe, ES, Krenacs, L, et al. Hepatosplenic T-cell lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:381–2.Google Scholar
Gaulard, P. Hepatosplenic T-cell lymphoma. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:631–9.Google Scholar
Belhadj, K, Reyes, F, Farcet, JP, et al. Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003;102:4261–9.Google Scholar
Willemze, R, Paulli, M, Kadin, ME. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed.. Lyon, France: IARC Press; 2017:392–6.Google Scholar
Kempf, W, Kerl, K, Mitteldorf, C. Cutaneous CD30-positive T-cell lymphoproliferative disorders – clinical and histopathologic features, differential diagnosis, and treatment. Semin Cutan Med Surg. 2018;37:24–9.Google Scholar
Kadin, ME, Kempf, W. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:731–45.Google Scholar
Jaffe, ES, Gaulard, P, Cerroni, L. Subcutaneous panniculitis-like T-cell lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:383–5.Google Scholar
Cerroni, L. Primary cutaneous T-cell lymphomas: Rare subtypes. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:747–60.Google Scholar
Gaulard, P, Berti, E, Willemze, R, et al. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:401–2.Google Scholar
Beltraminelli, H, Leinweber, B, Kerl, H, et al. Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases. Am J Dermatopathol. 2009;31:317–22.Google Scholar
Quintanilla-Martinez, L, Ko, YH, Kimura, H, et al. EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:355–63.Google Scholar
Ko, YH, Chan, JKC, Quintanilla-Martinez, L. Virally associated T-cell and NK-cell neoplasms. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:565–98.Google Scholar
Cohen, JI, Manoli, I, Dowdell, K, et al. Hydroa vacciniforme–like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites. Blood. 2019;133:2753–64.Google Scholar
Liu, Y, Ma, C, Wang, G, et al. Hydroa vacciniforme–like lymphoproliferative disorder: Clinicopathologic study of 41 cases. J Am Acad Dermatol. 2019;81:534–40.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×